P

Praxis Precision Medicines

Clinical-stage biopharma developing CNS therapies

Clinical Development Leader - Epilepsies

Clinical Research OperationsConfirmed live in the last 24 hours
Full-timeRemote in USA$280k - $350k /yr

About the Job

Requirements

  • An advanced scientific degree (MD, PharmD, PhD, or equivalent) is required.
  • A track record of personally leading clinical trials, programs, submissions, or major development decisions.
  • Experience owning regulatory submissions, including carrying the clinical content of IND, CTA, NDA, or MAA filings, briefing books, and health authority interactions.
  • Strong judgment and the ability to make thoughtful, timely decisions on emerging data with incomplete information, including knowing what to escalate and when.
  • Comfort operating in a dynamic environment where priorities and scope shift and ownership matters more than rigid role boundaries.

Responsibilities

  • Apply deep understanding of adult and pediatric epilepsy, trial design, endpoints, and the regulatory pathway, including pediatric requirements such as PIP and PSP, to development strategy and decision-making.
  • Translate science, emerging data, patient needs, and regulatory requirements into development strategies, and personally lead studies from design through execution.
  • Interpret emerging clinical and scientific data, identify what matters, and make timely decisions when information is incomplete.
  • Own substantive clinical content for regulatory filings, briefing materials, and health authority interactions.
  • Drive cross-functional teams across clinical operations, biostatistics, regulatory, safety, and other disciplines to resolve issues and move programs forward.
  • Use program and submission experience to strengthen other clinical leaders, expanding their judgment, ownership, and ability to lead increasingly complex development work.
  • Represent Praxis with investigators, key opinion leaders, health authorities, and partners.

Desired Qualifications

  • Take ownership, challenge assumptions with scientific rigor, move with urgency without sacrificing quality, and stay focused on patient outcomes.

About the Company

Praxis Precision Medicines

Clinical-stage biopharma developing CNS therapies

Praxis Precision Medicines develops therapies for central nervous system disorders driven by neuronal imbalance, with a focus on genetic epilepsies. Its treatments target restoring balance in CNS networks and are advanced in clinical development to address unmet medical needs. The company differentiates itself by using patient-guided development and forming partnerships to align with real patient needs. Its goal is to bring effective CNS therapies to patients and caregivers by advancing through clinical development toward potential commercialization and collaborations.

Company size
201-500
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2015

Recently Posted Jobs

Explore more opportunities at Praxis Precision Medicines

See more jobs